Stockscreener 앱 받기
0.1198
0.66%
-0.0008
시간 외 거래:
.12
0.0002
+0.17%
전일 마감가:
$0.1206
열려 있는:
$0.1203
하루 거래량:
3.75M
Relative Volume:
0.71
시가총액:
$117.40M
수익:
$25.19M
순이익/손실:
$-34.53M
주가수익비율:
-3.3278
EPS:
-0.036
순현금흐름:
$-20.62M
1주 성능:
-0.75%
1개월 성능:
-4.39%
6개월 성능:
-12.04%
1년 성능:
-6.48%
1일 변동 폭
$0.1197
$0.1209
1주일 범위
$0.1197
$0.122
52주 변동 폭
$0.117
$0.1952
조메디카 Stock (ZOM) Company Profile
명칭
Zomedica Corp
전화
734-369-2555
주소
100 Phoenix Drive, Suite 190, Ann Arbor, MI
ZOM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZOM
Zomedica Corp
|
0.1198 | 117.40M | 25.19M | -34.53M | -20.62M | -0.036 |
|
ZTS
Zoetis Inc
|
160.46 | 71.85B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.08 | 45.58B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.58B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.74 | 19.18B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.60 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
조메디카 Stock (ZOM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-06 | 개시 | Dawson James | Buy |
조메디카 주식(ZOM)의 최신 뉴스
Observations on the Zomedica Corp (AMEX:ZOM) Growth Curve - US Post News
Zomedica Corp [ZOM] stock for 18,450 USD was acquired by Blair Anthony K - Knox Daily
ZOMZomedica Corp. Latest Stock News & Market Updates - StockTitan
Zomedica Relocates Headquarters, Cuts Costs by $200,000 Annually -February 12, 2025 at 09:15 am EST - Marketscreener.com
Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters - ACCESS Newswire
Smart Money Move: Zomedica's New HQ Cuts Expenses in Half, Accelerates Path to Profits - StockTitan
Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners - ACCESS Newswire
Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference - ACCESS Newswire
Zomedica Corp [ZOM] Records 200-Day SMA of $0.1375 - Knox Daily
Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis - ACCESS Newswire
Experts predict Zomedica Corp’s (ZOM) current quarter earnings growth rate - US Post News
Zomedica Corp (ZOM) rating initates by Dawson James - Knox Daily
Zomedica (NYSEAMERICAN:ZOM) Shares Up 1.6%Here's Why - MarketBeat
Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared - ACCESS Newswire
US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians - ACCESS Newswire
Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line - ACCESS Newswire
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs - ACCESS Newswire
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System - ACCESS Newswire
Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels - ACCESS Newswire
Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 - ACCESS Newswire
Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform - ACCESS Newswire
Zomedica Continues Global Expansion Through Strategic Partnership with SIRE Veterinario, S.A for Sales Expansion in Central America - ACCESS Newswire
Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, Minnesota - ACCESS Newswire
Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product - ACCESS Newswire
Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET - ACCESS Newswire
Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024 - ACCESS Newswire
Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer - ACCESS Newswire
Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference - ACCESS Newswire
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market - ACCESS Newswire
Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe - ACCESS Newswire
A Bull Market Continues To Unfold On Zomedica Corp (AMEX: ZOM), As It Continued To Rise 3.67% In Year-To-Date - Marketing Sentinel
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth - ACCESS Newswire
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity - ACCESS Newswire
Noble Capital Markets Initiates Equity Research Coverage on Zomedica - ACCESS Newswire
Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2% – Here’s What Happened - Defense World
Geode Capital Management LLC Buys 321,395 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) - Defense World
Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2% – Here’s Why - Defense World
Zomedica (NYSEAMERICAN:ZOM) Shares Down 2.2%Should You Sell? - MarketBeat
Zomedica enters license and supply agreement with Cresilon Inc. - DVM 360
Zomedica Secures Exclusive U.S. Rights to Revolutionary Vetigel Bleeding Control Technology - StockTitan
Zomedica Unveils New Canine Tests Offering Faster Diagnostics for Heart and Breeding Health - AOL
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone - AccessWire
Zomedica Expands TRUFORMA Platform with Breakthrough 20-Minute Cardiac and Breeding Diagnostic Tests - StockTitan
Zomedica appoints Scott Jordan as EVP, finance & CFO - MSN
Zomedica (NYSEAMERICAN:ZOM) Trading Down 2.8% – Here’s Why - Defense World
Zomedica Strengthens Leadership: Industry Veteran with 30+ Years Experience Named New CFO - StockTitan
Zomedica (NYSEAMERICAN:ZOM) Trading Down 2.8%Should You Sell? - MarketBeat
Zomedica CEO to Present at NobleCon20 Conference, Investor Meetings Scheduled - StockTitan
Zomedica secures new lease for headquarters expansion By Investing.com - Investing.com South Africa
Zomedica secures new lease for headquarters expansion - Investing.com
Noble Financial Predicts Zomedica FY2024 Earnings - MarketBeat
조메디카 (ZOM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.23%
3.94%
자본화:
|
볼륨(24시간):